Novel DZ-artemisinin for treatment of pancreatic cancer

Ended Project Grant Awarded Last action

Award ID
W81XWH2210553
Recipient
Awarding agency
Obligated
$601,684

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date
Funding
  • $300,842.00 Federal
  • $300,842.00 Non-federal
Place of performance
West Hollywood, CA 90048, USA

Award details come from USAspending.gov.

About this award

Written by GovTribe AI ·

The Department of the Army Medical Command awarded Cedars-Sinai Medical Center a $601,684 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to support research on Novel DZ-Artemisinin for Treatment of Pancreatic Cancer. The three-year award beginning August 15, 2022 will fund the development of an innovative therapy using DZ-Artemisinin derivatives to treat pancreatic cancer at Cedars-Sinai's facilities located in West Hollywood, California. The Military Medical Research and Development program aims to transform military and public health through impactful biomedical research solutions, including investigating medical treatments for battlefield injuries. This award advances those goals by supporting the investigation of a potential new treatment for pancreatic cancer derived from plant-based compounds.

Quick answers

Who received award W81XWH2210553?

W81XWH2210553 was awarded to Cedars-Sinai Medical Center by Medical Command (Department of the Army) on August 15, 2022.

How much is award W81XWH2210553 worth?

$601,684 has been obligated on W81XWH2210553: $300,842 in federal funding and $300,842 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login